These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Design, engineering and in vitro evaluation of MHC class-II targeting allergy vaccines. Crameri R; Flückiger S; Daigle I; Kündig T; Rhyner C Allergy; 2007 Feb; 62(2):197-206. PubMed ID: 17298430 [TBL] [Abstract][Full Text] [Related]
3. [Artificial antigens for synthetic vaccines]. Swidsinski A; Swidsinski S Z Arztl Fortbild (Jena); 1988; 82(1):7-14. PubMed ID: 3285604 [No Abstract] [Full Text] [Related]
4. The duration of in vitro stimulation with recall antigens determines the subset distribution of interferon-gamma-producing lymphoid cells: a kinetic analysis using the Interferon-gamma Secretion Assay. Desombere I; Clement F; Rigole H; Leroux-Roels G J Immunol Methods; 2005 Jun; 301(1-2):124-39. PubMed ID: 15992817 [TBL] [Abstract][Full Text] [Related]
5. Induction of active immune suppression by co-immunization with DNA- and protein-based vaccines. Jin H; Kang Y; Zheng G; Xie Q; Xiao C; Zhang X; Yu Y; Zhu K; Zhao G; Zhang F; Chen A; Wang B Virology; 2005 Jun; 337(1):183-91. PubMed ID: 15914231 [TBL] [Abstract][Full Text] [Related]
6. Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. McConkey SJ; Reece WH; Moorthy VS; Webster D; Dunachie S; Butcher G; Vuola JM; Blanchard TJ; Gothard P; Watkins K; Hannan CM; Everaere S; Brown K; Kester KE; Cummings J; Williams J; Heppner DG; Pathan A; Flanagan K; Arulanantham N; Roberts MT; Roy M; Smith GL; Schneider J; Peto T; Sinden RE; Gilbert SC; Hill AV Nat Med; 2003 Jun; 9(6):729-35. PubMed ID: 12766765 [TBL] [Abstract][Full Text] [Related]
7. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma. Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252 [TBL] [Abstract][Full Text] [Related]
8. Recombinant Mycobacterium bovis BCG vector system expressing SIV Gag protein stably and persistently induces antigen-specific humoral immune response concomitant with IFN gamma response, even at three years after immunization. Kawahara M Clin Immunol; 2008 Dec; 129(3):492-8. PubMed ID: 18849196 [TBL] [Abstract][Full Text] [Related]
9. Viral recombinant vaccines to the E6 and E7 antigens of HPV-16. He Z; Wlazlo AP; Kowalczyk DW; Cheng J; Xiang ZQ; Giles-Davis W; Ertl HC Virology; 2000 Apr; 270(1):146-61. PubMed ID: 10772987 [TBL] [Abstract][Full Text] [Related]
10. Immuno-gene therapy of melanoma by tumor antigen epitope modified IFN-gamma. He X; Luo P; Tsang TC; Zhang T; Harris DT Cancer Immunol Immunother; 2005 Aug; 54(8):741-9. PubMed ID: 15726359 [TBL] [Abstract][Full Text] [Related]
11. Advances in the identification and characterization of protective antigens for recombinant vaccines against tick infestations. de la Fuente J; Kocan KM Expert Rev Vaccines; 2003 Aug; 2(4):583-93. PubMed ID: 14711342 [TBL] [Abstract][Full Text] [Related]
12. Recombinant BCG coexpressing Ag85B, ESAT-6 and mouse-IFN-gamma confers effective protection against Mycobacterium tuberculosis in C57BL/6 mice. Xu Y; Zhu B; Wang Q; Chen J; Qie Y; Wang J; Wang H; Wang B; Wang H FEMS Immunol Med Microbiol; 2007 Dec; 51(3):480-7. PubMed ID: 17919299 [TBL] [Abstract][Full Text] [Related]
14. Development of T cell-mediated immunity after autologous stem cell transplantation: prolonged impairment of antigen-stimulated production of gamma-interferon. van der Velden AM; Claessen AM; van Velzen-Blad H; Biesma DH; Rijkers GT Bone Marrow Transplant; 2007 Aug; 40(3):261-6. PubMed ID: 17563737 [TBL] [Abstract][Full Text] [Related]
15. Immunology and vaccinology of tuberculosis: can lessons from the mouse be applied to the cow? Orme IM Tuberculosis (Edinb); 2001; 81(1-2):109-13. PubMed ID: 11463231 [TBL] [Abstract][Full Text] [Related]
16. Murine immune responses to Schistosoma haematobium and the vaccine candidate rSh28GST. Lane A; Boulanger D; Riveau G; Capron A; Wilson RA Parasite Immunol; 1998 Aug; 20(8):359-67. PubMed ID: 9767601 [TBL] [Abstract][Full Text] [Related]
17. Factors influencing the immune response to foreign antigen expressed in recombinant BCG vaccines. Dennehy M; Williamson AL Vaccine; 2005 Jan; 23(10):1209-24. PubMed ID: 15652663 [TBL] [Abstract][Full Text] [Related]
18. Expressions of Bovine IFN-gamma and foot-and-mouth disease VP1 antigen in P. pastoris and their effects on mouse immune response to FMD antigens. Shi XJ; Wang B; Zhang C; Wang M Vaccine; 2006 Jan; 24(1):82-9. PubMed ID: 16135391 [TBL] [Abstract][Full Text] [Related]